Click image to enlarge
-
-
Specifications
-
Kit Contents
-
-
Documentation
-
References
|
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
|
Analyte(s)
|
|
IL-16
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
|
|
|
U-PLEX Group Compatibility
|
|
Biomarker Group 1
|
|
|
Plate Type
|
|
384-well
|
|
|
Capture Antibody
|
|
Mouse Monoclonal
|
|
|
Detection Antibody
|
|
Goat Polyclonal
|
|
|
LLOD (Sensitivity)
|
|
6.6 pg/mL
|
|
|
Dynamic Range
|
|
6.6-21,500 pg/mL
|
|
|
Sample Type
|
|
Plasma, Serum, Cell Culture Supernatant
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
3603
|
|
|
UniProt ID(s)
|
|
Q14005
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 each
(1 plate)
|
|
|
|
|
2-8 °C
|
2 bottle
(50 mL)
|
|
|
|
|
≤-10 °C
|
2 bottle
(40 mL)
|
|
|
|
|
≤-10 °C
|
2 bottle
(50 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
25 each
(1 plate)
|
|
|
|
|
2-8 °C
|
10 bottle
(50 mL)
|
|
|
|
|
≤-10 °C
|
10 bottle
(40 mL)
|
|
|
|
|
≤-10 °C
|
10 bottle
(50 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Product Highlights
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.
|
|
|
|
Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity.
|
|
|
|
Analytical performance validation of a coronary heart disease risk assessment multi-analyte proteomic test
|
|
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters